milrinone and pimobendan

milrinone has been researched along with pimobendan in 20 studies

Research

Studies (20)

TimeframeStudies, this research(%)All Research%
pre-19907 (35.00)18.7374
1990's10 (50.00)18.2507
2000's3 (15.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Friebe, WG; Kampe, W; Kling, L; Mertens, A; Müller-Beckmann, B; von der Saal, W1
Erhardt, PW1
Lombardo, F; Obach, RS; Waters, NJ1
Abe, Y; Kitada, Y; Narimatsu, A1
Lehot, JJ1
Meyer, W; Scholz, H1
Braunwald, E; Colucci, WS; Wright, RF1
Driscoll, EM; Frye, JW; Kitzen, JM; Lucchesi, BR; Lynch, JJ; Uprichard, AC1
Brunkhorst, D; Meyer, W; Nigbur, R; Schmidt-Schumacher, C; Scholz, H; v der Leyen, H1
Fujino, K; Solaro, RJ; Sperelakis, N1
Chiotti, D; Presbitero, P1
Fujimoto, S1
Abe, Y; Ishisu, R; Nakano, T; Narimatsu, A; Onishi, K; Sekioka, K1
Hettrick, DA; Pagel, PS; Warltier, DC1
Erdmann, E1
Kitada, Y1
Conti, M; Hanssen, RG; Hirsch, B; Hsueh, AJ; Kloosterboer, HJ; Tsafriri, A; Van de Kant, M; Wiersma, A1
Arita, M; Dohi, K; Kiyosue, T; Matsui, K; Wang, JC1
Kimura, T; Kuwashima, H; Matsumura, C1
Sato, N1

Reviews

4 review(s) available for milrinone and pimobendan

ArticleYear
In search of the digitalis replacement.
    Journal of medicinal chemistry, 1987, Volume: 30, Issue:2

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Cardiotonic Agents; Cyclic AMP; Digitalis Glycosides; Heart Failure; Humans; Myocardial Contraction; Receptors, Adrenergic, beta; Structure-Activity Relationship

1987
New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 2.
    The New England journal of medicine, 1986, Feb-06, Volume: 314, Issue:6

    Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Administration, Oral; Aminopyridines; Amrinone; Cardiotonic Agents; Coenzymes; Enoximone; Heart; Heart Failure; Hemodynamics; Humans; Imidazoles; Injections, Intravenous; Milrinone; Nifedipine; Oxyfedrine; Phosphodiesterase Inhibitors; Pyridazines; Pyridones; Quinazolines; Ubiquinone

1986
[New inotropic drugs].
    Cardiologia (Rome, Italy), 1988, Volume: 33, Issue:8

    Topics: Adrenergic beta-Agonists; Amrinone; Cardiotonic Agents; Deoxyepinephrine; Enoximone; Ethanolamines; Heart; Humans; Imidazoles; Milrinone; Myocardial Contraction; Propanolamines; Pyridazines; Pyridones; Vasodilator Agents; Xamoterol

1988
[Phosphodiesterase III inhibitor--characteristics, mechanisms of action, pharmacokinetics, indications, contraindications, clinical trials, and side effects].
    Nihon rinsho. Japanese journal of clinical medicine, 2007, May-28, Volume: 65 Suppl 5

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Cardiotonic Agents; Clinical Trials as Topic; Contraindications; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Humans; Imidazoles; Milrinone; Phosphodiesterase Inhibitors; Pyridazines; Pyridones

2007

Other Studies

16 other study(ies) available for milrinone and pimobendan

ArticleYear
Nonsteroidal cardiotonics. 3. New 4,5-dihydro-6-(1H-indol-5-yl)pyridazin-3(2H)-ones and related compounds with positive inotropic activities.
    Journal of medicinal chemistry, 1990, Volume: 33, Issue:10

    Topics: Animals; Cardiotonic Agents; Cats; Chemical Phenomena; Chemistry, Physical; Dogs; Dose-Response Relationship, Drug; Milrinone; Molecular Structure; Myocardial Contraction; Pyridazines; Pyridones; Rats; Structure-Activity Relationship; Time Factors

1990
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Beneficial effect of MCI-154, a cardiotonic agent, on ischemic contractile failure and myocardial acidosis of dog hearts: comparison with dobutamine, milrinone and pimobendan.
    The Journal of pharmacology and experimental therapeutics, 1992, Volume: 261, Issue:3

    Topics: Acidosis; Animals; Cardiotonic Agents; Coronary Disease; Dobutamine; Dogs; Female; Hemodynamics; Hydrogen-Ion Concentration; Male; Milrinone; Myocardial Contraction; Pyridazines; Pyridones

1992
[New positive inotropic drugs].
    Annales francaises d'anesthesie et de reanimation, 1991, Volume: 10, Issue:1

    Topics: Adrenergic Agonists; Amrinone; Cardiotonic Agents; Dopamine; Enoximone; Hemodynamics; Humans; Imidazoles; Milrinone; Myocardial Contraction; Phosphodiesterase Inhibitors; Pyridazines; Pyridones; Shock, Cardiogenic

1991
Phosphodiesterase-inhibiting properties of newer inotropic agents.
    Circulation, 1986, Volume: 73, Issue:3 Pt 2

    Topics: 1-Methyl-3-isobutylxanthine; Aminopyridines; Amrinone; Animals; Calcium; Cardiotonic Agents; Cyclic AMP; Dose-Response Relationship, Drug; Guinea Pigs; Imidazoles; Milrinone; Myocardial Contraction; Phosphodiesterase Inhibitors; Pyridazines; Pyridones; Theophylline

1986
Effects of the positive inotropic agents milrinone and pimobendan on the development of lethal ischemic arrhythmias in conscious dogs with recent myocardial infarction.
    Journal of cardiovascular pharmacology, 1989, Volume: 14, Issue:4

    Topics: Animals; Arrhythmias, Cardiac; Cardiotonic Agents; Coronary Vessels; Dogs; Electric Stimulation; Electrocardiography; Female; Heart Rate; Male; Milrinone; Myocardial Infarction; Pyridazines; Pyridones

1989
Relation of positive inotropic and chronotropic effects of pimobendan, UD-CG 212 Cl, milrinone and other phosphodiesterase inhibitors to phosphodiesterase III inhibition in guinea-pig heart.
    Naunyn-Schmiedeberg's archives of pharmacology, 1989, Volume: 339, Issue:5

    Topics: Animals; Cardiotonic Agents; Guinea Pigs; Heart; Heart Rate; In Vitro Techniques; Isoenzymes; Milrinone; Myocardial Contraction; Myocardium; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pyridazines; Pyridones

1989
Sensitization of dog and guinea pig heart myofilaments to Ca2+ activation and the inotropic effect of pimobendan: comparison with milrinone.
    Circulation research, 1988, Volume: 63, Issue:5

    Topics: Actin Cytoskeleton; Action Potentials; Adenosine Triphosphatases; Animals; Calcium; Cardiotonic Agents; Cyclic AMP; Cytoskeleton; Dogs; Guinea Pigs; Heart; In Vitro Techniques; Male; Milrinone; Myocardial Contraction; Myocardium; Pyridazines; Pyridones; Troponin; Troponin C

1988
Effects of pimobendan, its active metabolite UD-CG 212, and milrinone on isolated blood vessels.
    European journal of pharmacology, 1994, Nov-24, Volume: 265, Issue:3

    Topics: Animals; Cardiotonic Agents; Glyburide; Guinea Pigs; In Vitro Techniques; Male; Milrinone; Muscle, Smooth, Vascular; Phosphodiesterase Inhibitors; Pyridazines; Pyridones; Rats; Rats, Wistar; Vasodilator Agents

1994
Calcium sensitization in perfused beating guinea pig heart by a positive inotropic agent MCI-154.
    The Journal of pharmacology and experimental therapeutics, 1996, Volume: 276, Issue:2

    Topics: Animals; Calcium; Cardiotonic Agents; Fluorescence; Guinea Pigs; Indoles; Male; Milrinone; Myocardium; Perfusion; Phosphodiesterase Inhibitors; Pyridazines; Pyridones; Ventricular Function, Left

1996
Influence of levosimendan, pimobendan, and milrinone on the regional distribution of cardiac output in anaesthetized dogs.
    British journal of pharmacology, 1996, Volume: 119, Issue:3

    Topics: Anesthesia; Animals; Cardiac Output; Dogs; Female; Hemodynamics; Hydrazones; Male; Milrinone; Phosphodiesterase Inhibitors; Pyridazines; Pyridones; Regional Blood Flow; Simendan

1996
The effect of positive inotropes on the failing human myocardium.
    Cardiology, 1997, Volume: 88 Suppl 2

    Topics: 1-Methyl-3-isobutylxanthine; Adrenergic beta-Agonists; Calcium; Cardiotonic Agents; Dobutamine; Heart Failure; Humans; In Vitro Techniques; Isoproterenol; Milrinone; Myocardial Contraction; Papillary Muscles; Phosphodiesterase Inhibitors; Pyridazines; Pyridones

1997
MCI-154, a cardiac Ca2+ sensitizer, reverses the depression in maximal Ca2+-activated force by inorganic phosphate and acidic pH in skinned fiber of guinea pig heart.
    Cardiovascular drugs and therapy, 1997, Volume: 11, Issue:5

    Topics: Animals; Calcium; Cardiotonic Agents; Guinea Pigs; Heart; Heart Ventricles; Hydrogen-Ion Concentration; In Vitro Techniques; Milrinone; Myocardial Contraction; Phosphates; Pyridazines; Pyridones; Ventricular Function

1997
Phosphodiesterase 3 inhibitors suppress oocyte maturation and consequent pregnancy without affecting ovulation and cyclicity in rodents.
    The Journal of clinical investigation, 1998, Aug-01, Volume: 102, Issue:3

    Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Contraceptive Agents, Female; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Estrus; Female; Fertilization; Heart Rate; Hypoxanthine; Isoenzymes; Meiosis; Menotropins; Mice; Mice, Inbred C57BL; Milrinone; Oogenesis; Ovarian Follicle; Ovulation; Ovulation Induction; Phosphodiesterase Inhibitors; Pregnancy; Purinones; Pyridazines; Pyridones; Pyrrolidinones; Quinolones; Rats; Rats, Sprague-Dawley; Rolipram; Second Messenger Systems; Substrate Specificity; Thiophenes

1998
Effects of pimobendan on the L-type Ca2+ current and developed tension in guinea-pig ventricular myocytes and papillary muscle: comparison with IBMX, milrinone, and cilostazol.
    Cardiovascular drugs and therapy, 1999, Volume: 13, Issue:2

    Topics: 1-Methyl-3-isobutylxanthine; Animals; Calcium Channels; Cardiotonic Agents; Cilostazol; Guinea Pigs; Heart Ventricles; In Vitro Techniques; Milrinone; Myocardial Contraction; Papillary Muscles; Patch-Clamp Techniques; Phosphodiesterase Inhibitors; Pyridazines; Tetrazoles

1999
Inhibition and facilitation by pimobendan, a calcium sensitizer, of catecholamine secretion from bovine adrenal chromaffin cells.
    Journal of pharmacological sciences, 2003, Volume: 91, Issue:3

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Acetylcholine; Adrenal Glands; Amrinone; Angiotensin II; Animals; Calcium; Catecholamines; Cattle; Cells, Cultured; Chromaffin Cells; Cyclic AMP-Dependent Protein Kinases; Cyclic Nucleotide Phosphodiesterases, Type 3; Dimethylphenylpiperazinium Iodide; Histamine; Isoquinolines; Milrinone; Potassium; Pyridazines; Sulfonamides

2003